The Cholesterol Theory
The general theory is that if you have too much cholesterol in your blood, it can result in plaque buildup on the artery walls, which can lead to the narrowing or hardening of your arteries. This increases the risk of blood clots, heart disease, heart attacks, and stroke. By reducing cholesterol production, the idea is that statins lower the chance of plaque buildup, and consequently, blood clots, heart disease, heart attacks, and stroke. But is this theory true, and does reducing cholesterol production save lives?
There is a difference between relative risk and absolute risk. Drug A can reduce your risk of developing a condition by 0.5 percent. That’s your absolute risk. On the other hand, Drug B can decrease your risk by bringing it down from 0.5 to 0.25 percent.
How do you report this? There are two ways to go about this.
• Your relative risk was lowered by 50 percent from 0.5 to 0.25 percent when using Drug B.
• Or you can report the absolute risk, which means that Drug B only lowered the risk by a mere 0.25 percent.
Reporting the relative risk sounds much more impressive and can inflate the benefits of a medication or other treatment. This is what happened with statin drug studies as well.
A 2017 meta-analysis published in The Lancet looked at 26 randomized trials. (1) They found that statin drugs can decrease mortality by 10 percent for every 39 mg/dL. However, if you look at the trials closer, the mortality rates went from 2.3 to 2.1 percent for every 39 mg/dL, resulting in only a 0.2 percent absolute risk reduction. Looking at vascular-related death, statin drugs only decreased death from 1.3 to 1.2 percent.
Is that much of a percentage worth the risk and side-effects of taking a statin drug when there are SO many other options for lowering cholesterol?